Review of Salvage Therapy for Biochemically Recurrent Prostate Cancer: The Role of Imaging and Rationale for Systemic Salvage Targeted Anti-Prostate-Specific Membrane Antigen Radioimmunotherapy
Despite local therapy with curative intent, approximately 30% of men suffer from biochemical relapse. Though some of these PSA relapses are not life threatening, many men eventually progress to metastatic disease and die of prostate cancer. Local therapy is an option for some men, but many have prog...
Main Authors: | Satyajit Kosuri, Naveed H. Akhtar, Michael Smith, Joseph R. Osborne, Scott T. Tagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Advances in Urology |
Online Access: | http://dx.doi.org/10.1155/2012/921674 |
Similar Items
-
Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer following Primary Brachytherapy
by: John M. Lacy, et al.
Published: (2016-01-01) -
Salvage conformal radiotherapy for biochemical recurrent prostate cancer after radical prostatectomy
by: Carlos R. Monti, et al.
Published: (2006-08-01) -
Performance and Impact of Prostate Specific Membrane Antigen-Based Diagnostics in the Management of Men with Biochemical Recurrence of Prostate Cancer and Its Role in Salvage Lymph Node Dissection
by: Marieke J. Krimphove, et al.
Published: (2020-01-01) -
Salvage prostate cryoablation for recurrent localized prostate cancer after radiotherapy
by: Justin Ji-Yuen Siu, et al.
Published: (2016-12-01) -
Salvage radiotherapy of prostate cancer recurrences after radical prostatectomy
by: S. I. Tkachev, et al.
Published: (2018-04-01)